Live tape
Top 8, mentions 7d30,017NVDA14,564 mentions▲ +0.04ANT4,160 mentions▲ +0.06GOOGL2,936 mentions▲ +0.04SPY2,248 mentions▲ +0.05QQQ1,804 mentions▲ +0.04SPCX1,748 mentions▲ +0.08AMD1,367 mentions▲ +0.06AAPL1,190 mentions▲ +0.04

Equity · Healthcare

RAPP

NASDAQ

Rapport Therapeutics (RAPP)

23.16 USD −1.95% vs prior close Nov 20, 2026
Rapport Therapeutics, Inc. price graph
37 sessions
60 20 24 Aug 20 Nov

The line runs 49 USD on 24 August through 23.16 USD on 20 November, on a scale from 20 to 60. Days the market did not trade hold the previous close, flat.

Market cap
1.4B USD
EPS, diluted, year to Dec 2025
−2.86 USD
52-week range
22.10 USD – 52 USD
Avg volume
65.9K
Mentions, 30 days
7
Net sentiment
+0.10

as of Nov 20, 2026

Have Rapport Therapeutics (RAPP) insiders bought or sold shares recently?

In the 90 days to 22 Nov 2026, Rapport Therapeutics insiders reported 9 open-market sales and 7 purchases (SEC Form 4).

Form 4, 90 days to 22 Nov 2026, newest reported trade 28 Oct 2026

7buys
9sells
$17.55Mnet bought
1other filings
Have Rapport Therapeutics (RAPP) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
28 Oct 2026HEALY JAMESDirectorBuy969,48020.4M USD
23 Oct 2026Sanchez RamiroDirectorBuy3,60098K USD
22 Oct 2026MARAGANORE JOHNDirectorBuy9,411249K USD
22 Oct 2026PAUL STEVEN MDirectorBuy35,714974K USD
22 Oct 2026Young Wendy B.DirectorBuy3,789100K USD
22 Oct 2026Silva Paul MDirectorBuy3,680100K USD
21 Oct 2026Ignelzi Troy A.Chief Financial OfficerBuy5,500144K USD
21 Oct 2026Ceesay AbrahamChief Executive OfficerSell2,21064K USD
07 Oct 2026Ceesay AbrahamChief Executive OfficerSell1,14735K USD
06 Oct 2026Ceesay AbrahamChief Executive OfficerSell3,375108K USD
30 Sep 2026Gault CherylChief Operating OfficerSell10,000332K USD
23 Sep 2026Ceesay AbrahamChief Executive OfficerSell2,21087K USD
Bought7 open-market purchases1,031,174$22.02M
Sold9 open-market sales96,233$4.47M

Showing the 12 most recent of 16 open-market trades in this window. The figures above count all of them.

1 other filing in the window: a grant, exercise, tax withholding or transfer, not a trade
Have Rapport Therapeutics (RAPP) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
30 Oct 2026Third Rock Ventures V, L.P.DirectorAward1,428,57130.0M USD

Which funds hold Rapport Therapeutics (RAPP)?

6 of the 45 institutional funds we track reported a Rapport Therapeutics position for the quarter ended 30 Sep 2026 — a combined 61.8M USD; the latest of those filings landed 16 Nov 2026.

Form 13F

Which funds hold Rapport Therapeutics (RAPP)?
FundPositionSharesValueShares q/q
Baker Bros. AdvisorsHeld (±25%)1,547,09052.0M USD
D. E. Shaw & Co.Trimmed114,3183.8M USD−46.8%
Millennium ManagementTrimmed68,1182.3M USD−56.0%
Two Sigma InvestmentsAdded65,7962.2M USD+168.9%
AQR Capital ManagementHeld (±25%)27,833935K USD+5.2%
Citadel AdvisorsTrimmed15,289514K USD−81.5%

What has been filed or recorded for Rapport Therapeutics (RAPP)?

The filings we hold for Rapport Therapeutics, newest first: 3 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 4 reported financial figures, the latest dated 29 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Rapport Therapeutics (RAPP)?
And
29 Oct 2026Fails to deliverShares failed to deliver156,377 shares3.5M USD notional · 0.264% of shares out
26 Oct 2026Fails to deliverShares failed to deliver559 shares14K USD notional · 0.001% of shares out
21 Oct 2026Fails to deliverShares failed to deliver31 shares910 USD notional · <0.001% of shares out
30 Sep 2026Quarterly earningsQ3 2026 reportedEPS −0.84 USD
30 Sep 2026FinancialsTotal assets418.6M USDat period end
30 Sep 2026FinancialsTotal equity391.2M USDat period end
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS −1.19 USD
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS −0.42 USDRevenue $20M
31 Dec 2025Annual reportFY 2025 reportedEPS −2.86 USD
31 Dec 2025FinancialsNet income−111.5M USDfiscal year
31 Dec 2025FinancialsDiluted EPS−2.86 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS −0.71 USD
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS −0.75 USD
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS −0.68 USD
31 Dec 2024Annual reportFY 2024 reportedEPS −3.78 USD

What is Reddit saying about Rapport Therapeutics (RAPP)?

Reddit mentioned RAPP 7 times in the 30 days to 21 November 2026, in 1 of the communities we track. All of them were scored for sentiment: 71% read bullish, 0% bearish and 29% neither. Reddit data updated 21 November 2026.

30-day window, Method

7mentions, 30 days
71%bullish
0%bearish
1communities
+19pointsagainst the market

How do Reddit mentions of Rapport Therapeutics (RAPP) compare with its price?

Share ↗
7 mentions

Which subreddits are talking about Rapport Therapeutics (RAPP)?

30 days

Which subreddits are talking about Rapport Therapeutics (RAPP)?
CommunityShareMentionsNet sentiment
r/stocks100%7+0.10

What do people ask about Rapport Therapeutics (RAPP)?

From live data
What did Rapport Therapeutics shares close at?23.16

Rapport Therapeutics closed at 23.16 USD on 20 Nov 2026, down 1.95% on the close before. That is the end-of-day price from Finazon, not a live quote.

What is Rapport Therapeutics’ market cap?1.4B

Rapport Therapeutics is worth 1.4B USD by market value as of 20 Nov 2026, which is the share price times the shares on issue from its SEC filings.

Have Rapport Therapeutics insiders bought or sold shares recently?9 sales

In the 90 days to 22 Nov 2026, Rapport Therapeutics insiders reported 9 open-market sales and 7 purchases (SEC Form 4). A further 1 filing was a grant, award, gift or exercise rather than an open-market trade. See Insiders

Which funds own Rapport Therapeutics?6 of 45

6 of the 45 funds we track reported a Rapport Therapeutics position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were Baker Bros. Advisors, D. E. Shaw & Co. and Millennium Management. See Funds

When did Rapport Therapeutics last report earnings?−0.84

Rapport Therapeutics last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.84 USD; no next date is announced in SEC filings yet. See Filings

What is Reddit saying about Rapport Therapeutics?0 mentions

Rapport Therapeutics was mentioned 0 times in the last 7 days across the finance subreddits we track, and 7 times over the trailing 30 days. Of the 7 mentions scored for sentiment, 71% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. RedditReddit ingest across the tracked finance subreddits
  4. SEC EDGARForm 4 filings (insider transactions)
  5. SEC EDGAR13F filings
  6. SECSEC fails-to-deliver (CNS) data
  7. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  8. SEC EDGARreported earnings figures and scheduled report dates
  9. SEC EDGARValuation computed from SEC EDGAR filings
  10. SEC filingAbout text: the company's latest annual report filed with the SEC (Business section), summarised in our own words